Rosalyn D Blumenthal, Ph. D. , Alice P Taylor, Ph. D

Slides:

Advertisements

Similar presentations

Pregnancy rates after embryo transfer depend on the provider at embryo transfer22 Rhonda M Hearns-Stokes, M.D., Bradley T Miller, M.D., Lynette Scott,

Advertisements

Early-stage endometriosis: adhesion and growth of human menstrual endometrium in nude mice Michelle Nisolle, M.D., Ph.D., Françoise Casanas-Roux, B.S.,

Rhona Stein, Ph.D., David M. Goldenberg, Sc.D., M.D. CHEST

TAGLN expression is deregulated in endometriosis and may be involved in cell invasion, migration, and differentiation Gabriela dos Santos Hidalgo, M.Sc.,

Relationship between oxidative stress, semen characteristics, and clinical diagnosis in men undergoing infertility investigation Fabio F Pasqualotto,

Sachiko Matsuzaki, M. D. , Takashi Murakami, M. D. , Shigeki Uehara, M

Genome-based expression profiling as a single standardized microarray platform for the diagnosis of endometrial disorder: an array of 126-gene model

Expression of vascular endothelial growth factor-A and its receptor-1 in a luteal endometrium in patients with repeated in vitro fertilization failure

Age at menarche: a predictor of diminished ovarian function?

Increased expression of c-fos protein associated with increased matrix metalloproteinase-9 protein expression in the endometrium of endometriotic patients

Thyroid-stimulating hormone receptor and thyroid hormone receptors are involved in human endometrial physiology Lusine Aghajanova, M.D., Ph.D., Anneli.

Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis Mohamed Khairy Mehasseb, M.B.B.Ch.,

Relationship between apoptosis and the number of macrophages in eutopic endometrium from women with and without endometriosis Donald P Braun, Ph.D.,

TAGLN expression is deregulated in endometriosis and may be involved in cell invasion, migration, and differentiation Gabriela dos Santos Hidalgo, M.Sc.,

Human uterine and ovarian expression of growth hormone–releasing hormone messenger RNA in benign and malignant gynecologic conditions Omid Khorram, M.D.,

Aldo Cavallini, B. Sc. , Leonardo Resta, M. D

Increased expression of p21-activated kinase in adenomyosis

Laura D. Almquist, M. D. , Creighton E. Likes, M. D

Effect of short-term hormone therapy on oxidative stress and endothelial function in African American and Caucasian postmenopausal women Raymond W Ke,

Qingxiang Wei, M. A. , J. Benjamin St. Clair, B. A. , Teresa Fu, B. A

Increased expression of p21-activated kinase 4 in adenomyosis and its regulation of matrix metalloproteinase-2 and -9 in endometrial cells Kyong Wook.

Expression of angiopoietins 1, 2 and their common receptor tie-2 in relation to the size of endothelial lining gaps and expression of VEGF and VEGF receptors.

Prospective evaluation of luteal phase length and natural fertility

Prolonged gonadotropin-releasing hormone agonist therapy reduced expression of nitric oxide synthase in the endometrium of women with endometriosis and.

Genome-based expression profiling as a single standardized microarray platform for the diagnosis of endometrial disorder: an array of 126-gene model

Immunohistochemical detection of aquaporin expression in eutopic and ectopic endometria from women with endometriomas Xiu-Xiu Jiang, M.D., Riu-Jin Wu,

Lusine Aghajanova, M. D. , Ph. D. , Signe Altmäe, Ph. D

Pathophysiologic features of “thin” endometrium

Kathryn Smith, M. D. , Redab Alnifaidy, Qingxiang Wei, M. A

Xiao-Yu Pan, Ph. D. , Xue Li, M. D. , Zhan-Ping Weng, Ph. D

Up-regulation of p21-activated kinase 1 by in vitro treatment with interleukin 1-beta and its increased expression in ovarian endometriotic cysts Mi.

Possible roles of oxytocin receptor and vasopressin-1α receptor in the pathomechanism of dysperistalsis and dysmenorrhea in patients with adenomyosis.

Immunohistochemical detection of heparanase-1 expression in eutopic and ectopic endometrium from women with endometriosis Xiulong Xu, Ph.D., Jianchi.

Lifetime expression of stem cell markers in the uterine endometrium

Protein profiling of human endometrial tissues in the midsecretory and proliferative phases of the menstrual cycle Tanu Parmar, M.S., Sushama Gadkar-Sable,

Rahi Victory, M. D. , F. R. C. S. C. , Ghassan M. Saed, Ph. D

Induction of endometrial plasminogen activator–inhibitor 1: a possible mechanism contributing to the effect of intrauterine levonorgestrel in the treatment.

Role of glucocorticoid receptor in the inhibitory effect of medroxyprogesterone acetate on the estrogen-induced endothelial nitric oxide synthase phosphorylation.

Lusine Aghajanova, M. D. , Ph. D. , Signe Altmäe, M. Sc

Pasquale Florio, M. D. , Ph. D. , Paulo B. Torres, M. D

Macrophage migration inhibitory factor expression in the intrauterine endometrium of women with endometriosis varies with disease stage, infertility status,

From partner's desk to iPad

Christophe Poncelet, M. D. , Ph. D. , Françoise Cornelis, M. D

Ana Luiza L. Rocha, M. D. , Patrizia Carrarelli, B. Sc

Philip Kressin, M. D. , Eva-Maria Wolber, Ph. D. , Harald Wodrich, Ph

Lois A. Salamonsen, Ph. D. , Tracey Edgell, Ph. D. , Luk J. F

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

CDB-2914, a novel selective progesterone receptor modulator, differentially regulates endometrial gene expression in the proliferative phase of the menstrual.

David E. Reichman, M. D. , Stacey A. Missmer, Sc. D. , Katharine F

GnRH antagonists may affect endometrial receptivity

Alterations in expression of endometrial endothelial nitric oxide synthase and αvβ3 integrin in women with endometriosis Omid Khorram, M.D., Ph.D., Bruce.

Estrogen therapy increases plasma concentrations of nitric oxide metabolites in postmenopausal women but increases flow-mediated vasodilation only in.

Effects of mifepristone on expression of endothelial nitric oxide synthase in human endometrium during the implantation phase Xiaoxi Sun, M.D., Xiaoyan.

M. Cecilia Johnson, Ph. D. , Manuel Maliqueo, M. Sc. , M

Impairment of male reproductive function after sleep deprivation

Regulation of assisted reproductive technologies in the United States

Lin Mu, Ph. D. , Wei Zheng, Ph. D. , M. D. , Liang Wang, Ph. D

Microvascular density, vascular endothelial growth factor A, and its receptors in endometrial blood vessels in patients with menorrhagia Miriam Mints,

Fernando M Reis, M. D. , Ph. D. , Ana Luiza Maia, M. D. , Ph. D

Munir Boodhwani, MD, MMSc, Neel R

Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis Xian-Jie Tan, Ph.D., Jing-He Lang, M.D., Dong-Yuan.

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

A study of luteal phase expression of inhibin, activin, and follistatin subunits in the endometrium of women with recurrent miscarriage Alka Prakash,

Nerve fibers and menstrual cycle in peritoneal endometriosis

Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation Reshef.

Umber Agarwal, M. R. C. O. G. , Soha El Sheikh, F. R. C. Path. , Ph. D

Patrizia Carrarelli, M. Sc. , Ana Luiza Lunardi Rocha, M. D

Expression of leukemia inhibitory factor in the endometrium in abnormal uterine cavities during the implantation window Ei Hasegawa, M.D., Hiroe Ito,

Expression of von willebrand’s factor, CD34, CD31, and vascular endothelial growth factor in uterine leiomyomas Christophe Poncelet, M.D., Patrick Madelenat,

Stephen J Winters, M. D. , Evelyn Talbott, David S Guzick, Ph. D. , M

Presentation transcript:

Abnormal expression of the angiopoietins and Tie receptors in menorrhagic endometrium Rosalyn D Blumenthal, Ph.D., Alice P Taylor, Ph.D., Lisa Goldman, Ph.D., Gloria Brown, M.S., David M Goldenberg, M.D., Sc.D. Fertility and Sterility Volume 78, Issue 6, Pages 1294-1300 (December 2002) DOI: 10.1016/S0015-0282(02)04276-0

FIGURE 1 Expression of growth factors and their receptors in proliferative phase non-menorrhagic (n = 7) and menorrhagic (n = 13) endometrium (upper panel) and in early midsecretory phase non-menorrhagic (n = 5) and menorrhagic (n = 6) endometrium. Results are expressed as the mean ± SD for each group. □ = nonmenorrhagia; ■ = menorrhagia. Blumenthal. ANG and Tie expression in menorrhagia.Fertil Steril 2002. Fertility and Sterility 2002 78, 1294-1300DOI: (10.1016/S0015-0282(02)04276-0)

FIGURE 2 Expression of growth factors and their receptors in premenopausal (n = 13) and postmenopausal (n = 4) menorrhagic endometrium. Results are expressed as the mean ± SD for each group. □ = non-menorrhagia; ■ = menorrhagia. Blumenthal. ANG and Tie expression in menorrhagia.Fertil Steril 2002. Fertility and Sterility 2002 78, 1294-1300DOI: (10.1016/S0015-0282(02)04276-0)

FIGURE 3 Expression of endothelial nitric oxide synthase (eNOS) in proliferative and early midsecretory non-menorrhagic □ (n = 7 and n = 6, respectively) and menorrhagic ■ (n = 13 and n = 6 for proliferative and secretory, respectively) endometrium. Results are expressed as the mean ± SD for each group. Blumenthal. ANG and Tie expression in menorrhagia.Fertil Steril 2002. Fertility and Sterility 2002 78, 1294-1300DOI: (10.1016/S0015-0282(02)04276-0)